Does simvastatin ameliorate diabetic cardiomyopathy by attenuating oxidative stress, inflammation, and apoptosis in rats?
Simvastatin demonstrates potential in alleviating diabetic cardiomyopathy through anti-inflammatory, anti-oxidative, and anti-apoptotic mechanisms in a rat model.
B in the diabetic heart. Cardiac caspase-3 was increased in the diabetic heart and decreased following treatment with simvastatin. In conclusion, our results suggest that simvastatin alleviates DCM by attenuating hyperglycemia/hyperlipidemia-induced oxidative stress, inflammation, and apoptosis.
Al‐Rasheed et al. (Sun,) studied this question.